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Different individuals possess slightly different genetic information and show genetically-determined differences
in several enzymeactivities due to genetic variability. Following an integrated approach,we studied the polymor-
phisms and methylation of sites contained in the 5′ ﬂanking region of themetabolizing enzyme CYP2E1 in corre-
lation to its expression in both tumor and non-neoplastic liver cell lines, since to date little is known about the
inﬂuence of these (epi)genetic elements in basal conditions and under induction by the speciﬁc inductor and a
demethylating agent. In treated cells, reduced DNA methylation, assessed both at genomic and gene level, was
not consistently associatedwith the increase of enzyme expression. Interestingly, the Rsa/Pst haplotype differen-
tially inﬂuenced CYP2E1 enzyme expression. In addition, regarding the Variable Number of Tandem Repeats
polymorphism, cells with A4/A4 genotype showed a greater expression inhibition (ranging from 20% to 30%)
compared with others carrying the A2/A2 one, while those cells bringing A2/A3 genotype showed an increase
of expression (of 25%, about). Finally, we demonstrated for the ﬁrst time that the A2 and A3 CYP2E1 alleles
play a more important role in the expression of the enzyme, compared with other (epi)genetic factors, since
they are binding sites for trans-acting proteins.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Because of the genetic variability, different individuals possess
slightly differing genetic information in their genomes for each gene;
in particular, the CYP multigenic family, whose members code for
xenobiotic-metabolizing enzymes, is one of the most polymorphic
ones in humans. Consequently, different individuals may have different
allelic variants of the same metabolizing gene and the resulting geno-
types can endow each individual with a peculiarly-different metaboliz-
ing capability and, ultimately, distinct phenotypic metabolic behavior
(Witkin et al., 2000). The phenotypic variation in the metabolism of
many substances was proven to be the consequence of genetically-
determined differences in the activities of a signiﬁcant number of
enzymes (Smith et al., 1995). For this reason it is interesting to study
the gene expression of ametabolizing enzyme in correlation to anything
that can bring to its diversiﬁcation, in order to isolate and identify some
environmental elements or lifestyles that can modify its normal func-
tion, causing a possible threat to human health.
The human enzyme CYP2E1 is a protein of about 62 kDa consisting
of 493 amino acid residues, involved in the metabolism of more than
80 hydrophobic toxic compounds and contributing to the activation of
many pro-carcinogens and certain drugs towards highly reactive
forms (Guengerich et al., 1991). In particular the enzyme CYP2E1 acti-
vates the N-nitrosamines contained in tobacco cigarettes and in food
(Wang et al., 2002), as well as in many carcinogens endogenous and/
or of industrial origin (Agundez, 2004). It is also able to reduce the
oxygen in highly reactive species, Reactive Oxygen Species (ROS),
such as the superoxide anion O −, the singlet oxygen 1O , hydrogen per-
oxide H O and hydroxyl radicals OH˙ determining multiple effects in
cells such as the denaturation of the proteins, the inactivation of en-
zymes and DNA mutations (Lu and Cederbaum, 2008).
The human CYP2E1 gene, located in 10q24.3 (Piao et al., 2003) is
induced by high levels of ethanol and its expression can be regulated
at various levels: transcriptional, translational, mRNA stabilization and
protein degradation (Lieber, 1999). Some Restriction Fragment Length
Polymorphisms (RFLP) and Variable Number of Tandem Repeats
(VNTR), contained in its 5′ ﬂanking region (Fig. 1), are relatively
known: a RFLP for enzymes RsaI and PstI generating two variants,
Rsa +/Pst− (named C1 haplotype) and Rsa−/Pst+ (named C2 haplo-
type), which are in complete linkage disequilibrium (Chao et al., 1995)
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and VNTR, generating four allelic forms: A1, A2, A3, A4 (Itoga et al.,
2001). In a previously published paper, our laboratory genotyped the
CYP2E1 VNTR polymorphisms in a cohort of regionalized subjects,
performing a Polymerase Chain Reaction-RFLP assay (PCR-RFLP),
highlighting a possible association between two VNTR genotypes
and the tendency to alcohol consumption and smoke, respectively
(Catanzaro et al., 2012a).
To date, little is known about the regulation of this gene, the inﬂu-
ence of polymorphisms in its expression and even less on methylation
of potential methylation sites (Botto et al., 1994; Hu et al., 1995)
(Fig. 1) as epigenetic regulatory elements. For this reason, we took
up the challenge of an integrated approach: in this work, we associated
epigenetic data with genetic polymorphism analysis (both RFLP and
VNTR), analyzing themethylation status of theCYP2E15′ ﬂanking region,
assessing enzyme expression in both untreated cells and treated with
the main inductor, ethanol, and a demethylating molecule, 5-
azacytidine. Finally, on the basis of the data obtained, we hypothesized
and demonstrated for the ﬁrst time that the VNTR polymorphisms of
the CYP2E1 gene have a more important role in the regulation of the
enzyme compared to other genetic and epigenetic factors being the
binding site for trans-agent molecules that modulate the expression of
the enzyme. We chose to conduct these studies on liver cell lines, both
tumor and non-neoplastic, to mimic the metabolic condition of the
main tissue where the CYP2E1 enzyme is functionally active.
2. Material and methods
2.1. Cell cultures and reagents
Hepato-cellular carcinoma (HCC) cell lines, Ha22T, HepG2, HuH7
and Chang liver cells, were routinely cultured as previously reported
(Catanzaro et al., 2012b). Brieﬂy, 1:1 DMEM-F12 (Invitrogen, USA), sup-
plemented with 10% fetal calf serum (Gibco, Invitrogen, Carlsbad, USA),
penicillin (100 U/ml) and streptomycin (100 μg/ml)was utilized as cul-
turemedium. Culturesweremaintained at 37 °C in a 5% CO2 humidiﬁed
incubator. Cells grown were harvested by trypsinization (0.25% Trypsin
with EDTA 4Na). Trypsin was therefore inactivated by the addition of
the growth medium.
Ethanol 100% (Carlo Erba, Italy) and 5-azacytidine (ZCyd, Sigma,
St. Louis) were micro-ﬁltered with 0.20 μm ﬁlter (Sartorius, Germany)
before dissolving in cultured medium. The doubling time of these cells
was ranging from 22 to 24 h.
2.2. Cell viability in untreated and exposed cells
In order to determine the best time and dose of ethanol and ZCyd
exposure, cell viability by Trypan Blue exclusion test was performed.
This test was carried out in a time course ranging from 24 h to 48 h of
increasing concentrations of drugs: the best results were found using
ethanol exposure (10, 25, 50 or 100 mM) or ZCyd treatment (1, 2.5, 5
or 10 μM) for 48 h.
In detail, cellswerewashed twicewithHanks' Balanced Salt Solution
and then harvested by trypsinization. 0.1 ml of cell suspension was
mixed 1:1 with 0.4% Trypan Blue Stain (Invitrogen, USA), maintained
for 5 min at room temperature; ﬁnally cells were counted in a Bürker
chamber under light microscope. The percentage of viable cells was
determined dividing the total number of viable cells perml of aliquot
and the total number of cells in the same volume (×100).
Regarding viability after treatments with 5-azacytidine (ZCyd), MTT
assay was also performed. Approximately 5 × 103 cells of each cell line
were seeded in a 96 wells cell culture plates (P96) for at least 18 h and
subsequently treated with ZCyd (1, 2.5, 5, 10 μM) for a time course
ranging from 24 to 48 h. At the end of the treatment the ZCyd was
appropriately removed and fresh culture medium (DMEM) and MTT
([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide])
were added in a ratio of 1:25 to each well. After treatment with MTT,
the plate was put in the dark and under stirring, at room temperature,
for 5 min and subsequently incubated at 37°°C in a 5% CO for 1 h.
After incubation, the P96 was centrifuged at 1800 rpm for 10 min,
the supernatant was discarded and dimethyl sulfoxide (DMSO) was
added, in order to solubilize the formazan crystals, and the P96 was
dark-incubated for 15 min at room temperature. The absorbance read
in a luminometer (λ = 560 nm) allowed us to determine the percent-
age of cell viability.
Using both untreated and treated cells, at least three independent
experiments were carried out for all the dose–response assays; data
were calculated as mean ± SD.
2.3. DNA extraction
Brieﬂy, about 1 × 106 cells were seeded in 10 mm tissue culture
dishes; after 18 h cells were (or not) exposed to ethanol or ZCyd for
48 h. At the end of the exposure the cells were washed twice with
Hanks' Balanced Salt Solution and then harvested by trypsinization,
re-suspended in fresh medium and ﬁnally pelleted by centrifugation
at 12,000 ×g for 10 min. Supernatant was carefully removed without
disturbing the pellet, then DNA from HCC cell lines and Chang liver,
was obtained using PureLink™ Genomic DNA Mini Kit according to
the manufacturer's protocol (Invitrogen, USA). The puriﬁed DNA was
quantiﬁed and stored at−20 °C.
2.4. RsaI/PstI polymorphism genotyping
A RFLP-PCR was used to genotype CYP2E1 RsaI/PstI polymorphism.
We set up the method previously described by Gao et al. (2007) with
some modiﬁcations developed in our laboratory. Brieﬂy, PCR was per-
formed using a ﬁnal volume of 50 μl containing 150 ng of genomic
DNA, 0.2 mM each dNTP, 1.5 mM MgCl2, 0.05 U/μl Taq polymerase
(Invitrogen, USA) and 0.5 μM of each primer (5′-CCAGTCGAGTCTACAT
TGTCA-3′sense and 5′-TTCATTCTGTCTTCTAACTGG-3′ anti-sense). PCR
was carried out by 5 min at 95 °C for initial melting and subsequent
30 thermal cycles under the following condition: 1 min at 55 °C for
primer annealing and 1 min at 72 °C for primer extension.
The PCR-ampliﬁed product is a 410 bp fragment of the transcrip-
tional regulation region of the gene CYP2E1. Half of the total amount
of the PCR product was separately subjected to enzyme restriction
with Rsa I and Pst I (0.5 U/μl) in a ﬁnal volume of 10 μl. To determine
the genotype, digested and non-digested samples were analyzed by a
12% polyacrylamide gel stained with SYBR Safe DNA gel (Invitrogen,
USA) and visualized by ChemiDoc XRS (Bio Rad, USA).
2.5. VNTR polymorphism genotyping
To genotype CYP2E1VNTR polymorphism,we carried out the specif-
ic PCR-technique performed in our laboratory and described elsewhere
Fig. 1. Diagram of 5′ ﬂanking region of CYP2E1 gene showing the position of VNTR region,
Rsa/Pst polymorphism and methylation sites, with respect to start site. In dashed the
reported position of HNF-1 transcriptional factor.
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(Catanzaro et al., 2012a). This technique consists in a conventional PCR
with speciﬁc primers (Itoga et al., 2002) and a subsequent restriction of
the PCR product with Nla IV endonuclease which is able to give a diges-
tion pattern speciﬁc for each VNTR genotype.
2.6. DNA methylation analysis
Methylation Sensitive Restriction Endonuclease-PCR (MSRE-PCR)
(Longo et al., 2013) was performed in order to determine the methyla-
tion status of the sites CpG rich, present in the 5′ ﬂanking region
(−849 bp and −457 bp to the start site, see Fig. 1) of the CYP2E1
gene. In a previous paper we made a distinction among three kinds of
cytosine, each potentially methylation site: the cytosine “CpG”, “CHH”
or “CHG”, where H are all nucleotides except G (Bellavia et al., 2013).
In the region described by Hu et al. (1995), containing the potential
methylation sites of CYP2E1 gene not canonically attributable to CpG
island, there were two CpG sites present, speciﬁcally detected by
isoschizomers HpaII and MspI (Biolabs, Europe), since the other sites
are CHH or CHG. We focused our investigation on these two CpG sites
whose methylation could be revealed by MSRE-PCR. We named these
sites 1M and 2M, respectively.
For each sample two independent digestionswith the isoschizomers
were carried out over night at 37 °C; typically 150 ng of DNA and 1 U
of the enzyme were used. At the end of the incubation, the digested
products were ampliﬁed using 0.5 M each primers (5′-TGC AAC CTA
TGA ATT AAG AAC-3′ sense and 5′-TAA AAG GAA AGA GTG AGT CAA-
3′antisense for 1M and 5′-GAT GTT GAA TTT TCC TTC TGG-3′ sense
and 5′-ATG GAG TTG GAC TGT GTC AAC-3′antisense for 2M), 0.2 mM
each dNTP, 1.5 mM MgCl2 and 0.05 U/μl of Taq (Invitrogen, USA). To
assess the genome-wide DNA methylation status of the cell lines, we
performed Methylation Sensitive Arbitrarily Primed-PCR (MeSAP-
PCR), as previously described (Caradonna et al., 2007). Since ethanol
has a speciﬁc effect on the CYP2E1 gene, and Cyd has amore generalized
genomic effect, we chose to investigate the genomic changes of DNA
methylation in ZCyd-treated cells, only.
Brieﬂy, this technique consists in an arbitrarily primed PCR ampliﬁ-
cation, in which genomic DNA, digested with a couple of endonuclease
(one of which being methylation sensitive), was used as template. The
DNA ﬁngerprinting, obtained from Polyacrylamide gel electrophoresis
of the PCR ampliﬁcations, was subjected to a densitometer scanning
using the software SigmaGel (Jandel Scientiﬁc, USA), by which it was
possible to count the number of disappeared, appeared, intensiﬁed or
attenuated bands. By these ﬁndings it is possible to have a measure of
the ZCyd treatment-induced changes in global DNAmethylation, partic-
ularly with regard to the CpG-rich sequences, as the used primer pos-
sessed a 3′ tail “CGCG”. Statistical analysis was done using Student's t
test comparing every HCC cell line to Chang liver cells; a value of at
least p b 0.05 was considered as signiﬁcant.
2.7. Determination of CYP2E1 enzyme expression by Western blotting
Western blot analyses were performed as previously reported
(Catanzaro et al., 2010).
The detection of the chemiluminescent signal was obtained by
Chemidoc XRS (Bio-Rad, USA) treating themembrane with SuperSignal
West Femto Chemiluminescent Substrates according to the manufac-
turer (Thermo Scientiﬁc, USA).
The normalized expression of CYP2E1 enzyme (β-tubulin, Santa
Cruz Biotechnology, Europe) was reported as histogram, derived from
densitometric scanning, using the software Sigma gel (Jandel Scientiﬁc,
USA), of the bands obtained by at least three Western blotting analysis.
Each expression variation of a treated cell line was compared with its
respective untreated. p value was calculated according to the χ2 test
and a value of p b 0.05 was considered signiﬁcant.
2.8. Cloning
To ensure a greater speciﬁcity in the EMSA, described below, we
chose to use fragments (containing the VNTR region of the CYP2E1
gene) cloned in Escherichia coli from previous CYP2E1 PCR product,
properly checked for compliance to the restriction map and sequenced.
All ampliﬁed fragments (VNTR variants) were fractionated using the
modiﬁed Voltage Gradient Gel Electrophoresis (VGGE) technique
(Bellavia et al., 2004) and then eluted as described elsewhere (Barbieri
et al., 1996). Eluted Amplicons were cloned in TOPO-TA plasmid, using
the TOPO-TA Cloning Kit, according to manufacturer's (Invitrogen™,
USA) speciﬁcations. All those colonies that resulted positive to colony
PCR, carried out using a pair of speciﬁc primers (T3: 5′ ATTAACCCTCAC
TAAAGGGA 3′; T7: 5′ TAATACGACTCACTATAGGG 3′), were initiated to
growth for 12 h at 37° C in LB with ampicillin and tetracycline. Then,
the plasmid DNAwas extractedwith the PureLinkMini prep kit accord-
ing to the manufacturer (Invitrogen™, USA), quantiﬁed and controlled
by serial reactions with restriction enzymes and sequenced to speciﬁ-
cally conﬁrm the real presence of the insert of our interest.
2.9. Electrophoretic Mobility Shift Assay (EMSA)
Previously cloned CYP2E1 A2 and A3 VNTR alleles, which are
suspected to contain a protein binding sequence, were ampliﬁed and la-
beled with biotin (Invitrogen, USA). Separately, without biotin labeling,
we obtained other cloned fragments as competitors or control: in
particular, we used the same A2 and A3 alleles as speciﬁc competitors;
we ampliﬁed a region of CDK2NA gene as a non-speciﬁc competitor
and,ﬁnallywe utilized A4 allele as a negative control, sincewe deducted
that it didn't contain a speciﬁc protein binding sequence.
All PCR reactions were prepared on the basis of the same protocol:
30 ng di DNA template; 1× buffer (10 mM K-phosphate buffer pH 7,
100 mMNaCl, 0.5 mM EDTA, 1 mMDTT, 0.01% Tween 20, 50% glycerol
(v/v)); dNTP 200 μM;MgCl2 1.5 mM; primers 1 pmol/μl; Taq 0.025 U/μl
(Invitrogen, Europe), in Thermalcycler PerkinElmer 9600, using the
following speciﬁc primer pairs (Catanzaro et al., 2012a; Dehghan
et al., 2008) in an appropriate PCR program: 1 cycle of denaturation
94 °C × 5′ and 30 cycle of denaturation 94 °C × 30″, annealing 60 °C ×
30″, extension 72 °C × 30″; 1 cycle of ﬁnal extension 72 °C × 5′ was
also carried out.
Both DNA fragments and Chang liver nuclear protein extracts were
incubated for 30 min at room temperature in 1.5 ml of the binding
solution (150 mM TRIS–HCl pH 7.9–100 mM KCl-10 mM DTT). Then,
the tubes, caps open, were exposed to UV light for about 30 min, to
carry out cross-link between the DNA fragments and the protein(s). The
samples were loaded onto a horizontal 12% acrylamide/bisacrylamide
gel (29:1 ratio) under non-denaturing conditions and at 300 V (Izzo
et al., 2006).
For blotting, a methanol-activated membrane (PVDF Membranes,
GE Healthcare, USA) incubated for 10 min in distilled H O and 15 min
in Transfer Buffer 1× [100 ml Transfer Buffer 10× (30.3 g Tris base,
144 g glycine, ddH2O up to the volume of 1 L), 800 ml ddH O, 100 ml
methanol] was used. Separately, the gel with resolved proteins was
incubated in transfer buffer 1× for 15 min. Then, the sandwich for
blotting was composed and the electro-blotting with 400 mA constant
current was carried out for 1 h at 4 °C.
After the full transfer, themembranewas incubated (with the side of
the complex DNA-protein facing upwards) in a denaturing solution
(0.4 M NaOH–1.5 M NaCl) for 20 min, subsequently in a neutralizing
solution (0.5 M Tris pH 7.5, 1.5 M NaCl) for 20 min. and ﬁnally in an
equilibration solution (2× SSC) for 20 min. Then, the membrane was
exposed for 2′ of UV light to perform the cross-linking between the
membrane and DNA protein complex. Successively, the membrane
was incubated for 1 h in hybridization solution (PBS 1×-Tween20
0.1%–5% free fatty acid milk), washed twice for 5 min each in PBS 1×-
Tween20 0.1% and ﬁnally incubated overnight, on a tilting table, at
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4 °C, in 10 ml of PBS 1×-Tween20 0.1%–3% BSA with 1:200 anti-biotin
monoclonal antibody (Roche, Europe). Then, the membrane was
washed three times, 10 min each,with PBS 1×-Tween20 0.1% and incu-
bated at room temperaturewithHRP-conjugated anti-rabbit IgG diluted
in 10 ml of PBS 1×-Tween20 0.1%–5% free fatty acid milk, for 1 h on
a tilting table. Lastly, three washes with PBS 1×-Tween20 0.1% for
10 min were performed.
The detection of the chemoluminescent signal was obtained by
Chemidoc XRS (Bio-Rad, USA) treating themembrane with SuperSignal
West Femto Chemoluminescent Substrates according to the manufac-
turer (Thermo Scientiﬁc, USA).
3. Results
3.1. Cell viability
In order to determine whether the treatments induced a reduction
of viability in hepato-cellular carcinoma (HCC) cell lines (Ha22t, Huh7,
HepG2) and in Chang liver cells, Trypan blue exclusion and MTT test
were used. Moreover, the cell viability assay determined the choice of
the best time and dose of exposure with ethanol and ZCyd in order to
exclude any lethal effects and/or clonal selection. In addition, since it
is well known that ZCyd action is more evident after the cell division,
the time of treatment took into account the doubling time of the cells
allowing them to accomplish at least two cell cycles.
Under 48 h treatment at determined doses of ethanol (10, 25, 50 or
100 mM) and ZCyd (1, 2.5, 5 or 10 μM), viability was always over LD50
in the three HCC cell lines and in Chang liver cells (data not shown).
3.2. CYP2E1 genotyping
RsaI/PstI and VNTR CYP2E1 genotypes were determined; Table 1
shows the obtained results. Regarding CYP2E1 Rsa/Pst polymorphism,
both Ha22T and HUH7 and Chang Liver showed the same genotype
(R+−/P−−) while HepG2 showed a different one (R++/P+−). It
is interesting to notice that all the four cell lines presented a non-
canonical genotype association, attributable neither to C1nor to C2hap-
lotype. Instead, regarding CYP2E1 VNTR polymorphism, only HepG2
and HUH7 presented the same genotype (A4/A4) while Chang liver
and Ha22T exhibited A2/A2 and A2/A3 genotypes respectively.
3.3. DNA methylation analysis
Methylation status of the two sites named 1M and 2M (−849 and
−457 bp from the start site, respectively) was assessed by MSRE-PCR
both in untreated and in ethanol- or ZCyd-treated cells. Results are
reported in Fig. 2.
Both untreated HCC lines and Chang liver showed a hypermethyla-
tion of the two sites, 1M and 2M, with the exception of the 2M site in
the HepG2 cells which appeared partially methylated. The response to
ethanol or ZCyd exposure was different among the four cell lines:
HepG2 cells seem to have the 2M site quick to demethylation in relation
to exposure, more to ethanol than to ZCyd, Chang Liver cells instead
showed a severe resistance to demethylation in both the sites and in re-
lation to every exposure.
Genome-wide methylation status, investigated in untreated and
ZCyd-treated cell lines, was analyzed by MeSAP-PCR. The results are
reported in Fig. 3 and Table 2. As expected, the global methylation
decreased in treated cells with respect to untreated ones; HCC cell
lines exhibited less genomic DNA methylation both in basal condition
even under ZCyd-treatment with respect to Chang Liver cells. In partic-
ular, HepG2 cells showed an elevated reduction of DNA methylation,
as attested by the high number of DNA methylation variations signiﬁ-
cantly different from those of normal cells, according to Student's t
test (p b 0.05).
3.4. CYP2E1 enzyme expression
In order to understand how 48 h treatments with ethanol or ZCyd
can affect CYP2E1 enzyme expression through a variation of the DNA
methylation of the CYP2E1 5′ ﬂanking region, we carried out Western
blot analyses using a polyclonal antibody against the CYP2E1 protein
in a discriminated total protein extracts of the untreated and treated
cell lines. The results are shown in Fig. 4.
In a ﬁrst overall view, it is evident that ZCyd is more effective than
ethanol at inducing CYP2E1 enzyme expression, but a more careful
analysis shows that no cell line showed any dose-dependent behavior
either under ethanol and ZCyd treatment. In particular, HepG2 cells
have an ethanol-only related enzyme expression while almost all
ZCyd-treated cell lines show a bell-trend enzyme expression, with an
initial increase, amaximum, and a ﬁnal decrease. All the expression var-
iations of treated cells, comparedwith their respective untreated values,
resulted not signiﬁcant, according to χ2 test.
3.5. Multiple correlation between ethanol- or ZCyd-inducted enzyme
expression and CYP2E1 5′ ﬂanking region DNA methylation
In order to evaluate whether and how changes in themethylation of
5′ ﬂanking region of theCYP2E1 gene, induced by treatmentwith ethanol
or with ZCyd, may affect the production of the enzyme, we correlated
the results obtained from the study of DNA methylation of the two
sites 1M and 2M with those regarding gene expression: essentially an
overlap between the data presented in Figs. 2 and 4. In addition to
what was previously said about the two phenomena separately consid-
ered, Fig. 5 demonstrated that there is no dose-dependent correlation
between ethanol/ZCyd treatments, 1M and 2M site demethylation,
and the enzyme expression.
3.6. Multiple correlation between ethanol or ZCyd-inducted CYP2E1
enzyme expression and CYP2E1 polymorphic genotypes
With the aim to correlate the effect of the polymorphic genotypes
in the induction of enzyme expression, we correlated the enzyme intra-
cellular amounts with possession of a certain polymorphic genotype,
either in basal condition (untreated cells) or under 48 h treatment
with ethanol or ZCyd. For this correlation, according to Wang et al.
(2009) we chose the average concentration of ethanol (25 mM) and
the average concentration of ZCyd (2.5 μM), since we know that it in-
duces the highest increase of protein expression.
The correlation demonstrates that HepG2 and HUH7 cells had a
lower basal enzyme expression, with respect to non-neoplastic cells;
they showed the same homozygous VNTR genotype (A4/A4), different-
ly from Chang liver and Ha22T cells. In the same graph it is possible to
see that Ha22T showed a greater enzyme expression, with respect to
control cells, having a heterozygous VNTR genotype (A2/A3). In general
it can be observed that the presence of a VNTR allele with a higher
number of repetitive units (in double dose) causes a decrease of enzyme
expression (Fig. 6A). Surprisingly, genotypically-equal treated cells
responded in different ways to ethanol or ZCyd induction (Fig. 6B): in
particular, it is more evident looking at the most different enzyme ex-
pression in those cells having the same Rsa/Pst polymorphism (Chang
Table 1
Rsa/Pst and VNTR CYP2E1 genotypes of HCC lines and Chang Liver cells.
Cell lines CYP2E1 polymorphisms
Rsa/Pst VNTR
Chang liver R+−/P−− A2/A2
Ha22T R+−/P−− A2/A3
HepG2 R++/P+− A4/A4
HuH7 R+−/P−− A4/A4
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liver, Ha22T and HuH7). Interestingly, looking at the ZCyd-treated cells
and their VNTR genotypes, it seems that the general observation previ-
ously enunciated, regarding the presence of a VNTR allele with a higher
number of repetitive units and decreasing of enzyme expression, is here
specularly inverted.
3.7. VNTR allele-protein interactions studies
A2 and A3 VNTR alleles were investigated for their capabilities to
interact with putative effector proteins, since those alleles, giving a
higher CYP2E1 enzyme expression in untreated cells, leave us to assume
that their action was mediated by trans-acting factors. Electrophoretic
Mobility Shift Assay (EMSA) was performed onto E. Coli-cloned CYP2E1
VNTR fragments in the presence or absence of nuclear protein extracts
of Chang Liver cells.
As it can be seen in Fig. 7A, both A2 and A3 VNTR alleles showed the
electrophoretic mobility shift, when they were put in the conditions to
bind speciﬁc cellular proteins. It is also important to note that these
DNA–protein interaction can be deﬁned “speciﬁc”, since mobility shift
was not observed in the presence of a speciﬁc competitor (added in
large excess and unlabeled) and, conversely, it was observed in the
presence of large quantities of unlabeled unspeciﬁc competitor. This
last ﬁndingwas equally seen, as expected, in the presence of large quan-
tities of unlabeled A4 allele, used as negative control, conﬁrming that
Fig. 2.Methylation status obtained byMSRE-PCR of the two sites 1M (A) and 2M (B) of the 5′-ﬂanking region of the CYP2E1 gene after 48 h ethanol (gray) or ZCyd (black) exposure. Error
bars represent the variable number of methylated cytosines obtained upon MspI enzyme methylation sensitivity.
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this large VNTR allele was not involved in any speciﬁc DNA–protein
interaction.
Moreover, Fig. 7B shows the ethidium bromide-stained polyacryl-
amide gel conducted with the two VNTR alleles before the
chemoluminescence detection. As it is clearly visible, the electrophoret-
ic analysis shows a differential mobility shift of A2 with respect to A3
allele, indicating a different DNA–protein interaction among these two
alleles.
4. Discussion
4.1. An integrated approach to study genetics and epigenetics of CYP2E1gene
The increasing interest of the scientiﬁc community for CYP genes is
today due to the possible correlation between the CYP enzymes and
the onset/maintenance of liver cancer and in particular, hepatocellular
carcinoma. The study of the regulation of the CYP2E1 gene is also timely
since it is well known that an inducer of its expression is acute ethanol
consumption, still rising, unfortunately, among the younger.
Therefore, clarifying the logical links among alcohol induction,
the expression of the CYP2E1 gene and liver tumors could be of crucial
importance and would be a great contribution in the ﬁeld of clinical/
diagnostic as well as an aid in understanding and management of the
social problem of alcoholism.
Few data regarding the regulation of gene expression of the gene
CYP2E1 have been reported so far and insufﬁcient results have been
published concerning the CYP2E1 5′ ﬂanking region in which are
contained both length or sequence polymorphisms as well as sites of
DNA methylation not canonically related to CpG islands (Hu et al.,
1995).
The data presented here are framed in this problem and represent
the ﬁrst attempts to clarify the dynamics of CYP2E1 enzyme expression
with an integrated approach, genetic and epigenetic, studying the
genetic variation (polymorphisms) and the epigenetic variation (DNA
methylation) in relation to the amount of the expressed protein
product. This work aims to be a study of functional correlation
(epi)genotype–phenotype that ﬁnd its reason in the equivalent impor-
tance of genotypic variations, such as polymorphisms (Watanabe et al.,
Fig. 3. DNA ﬁngerprinting obtained by MeSAP-PCR (left) and corresponding densitometric scanning (right) of some representative experiments. R, RsaI single digested DNA; RH, RsaI/
HpaII double digested DNA; bp, base pairs.
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1990), and epigenetic changes, such as differences in DNA methylation
(Lund and Van Lohuizen, 2004), in the expression of every gene and this
one, in particular.
The cell-system to which we have chosen to apply this approach is
represented by four cell lines: a non-neoplastic cell line (Chang Liver)
and three tumor cell lines (HA22T, HepG2 and HuH7). These cell lines,
being of hepatic origin, can mimic in vitro genomic and metabolic con-
ditions, since the CYP2E1 is a hepatic microsomal fraction enzyme
(Chao et al., 1995).
4.2. CYP2E1 genotyping
Several studies described the presence of two sequence polymor-
phisms associated with restriction sites for RsaI and PstI restriction
endonucleases in the 5′ ﬂanking region of the CYP2E1 gene (Watanabe
et al., 1990). In particular, some studies indicated that these two points
of polymorphism form a haplotype in complete linkage disequilibrium
(Chao et al., 1995), although a discrepancy in the association of these
two polymorphisms was described in African-American and Japanese
populations with a frequency of 6.8% and 4%, respectively (Kato et al.,
1992).
Our data explain that 3/4 cell lines show the same polymorphic
haplotype (Rsa+−/Pst−−) but this ﬁnding does not involve the
three tumor cell lines and therefore any association between this haplo-
type and the transformed phenotype cannot be directly assumed. Inter-
estingly, it should be noted that all the cell lines had a non-canonical
haplotype, attributable neither to C1 nor to C2 haplotype, suggesting
the hypothesis that these uncommon particular haplotypes could con-
stitute a selective advantage, favoring cell adaptation to in vitro growth.
Additionally, as it happens in all the in vitro established cell lines, it is
also possible that stabilization-induced/inducing chromosomal aberra-
tions may have produced supernumerary copies of chromosome 10 or
of 10q region. This can result in a generation of multiple copy number
of CYP2E1 gene which, towards a mutational divergence, could give a
complex and non-canonical Rsa/Pst haplotype to the cell lines.
Little is known about the length-polymorphisms of CYP2E1 gene:
only two reports described these VNTR alleles (Itoga et al., 2001; Lee
et al., 2008) and explained the composition of repeating units. The cell
lines we genotyped had different VNTR genotypes, except HuH7 and
HepG2 cells that showed both the A4/A4 genotype. More interesting
correlations will be reported in this work about the role of these less-
studied genetic variations and CYP2E1 enzyme expression.
4.3. DNA methylation analysis
In order to characterize the functional role of the methylation sites
described in the promoter of the CYP2E1 gene, we treated the four
cell lines with increasing doses of ethanol and ZCyd for 48 h. It is
worth noting that ethanol is a speciﬁc powerful positive modulator of
CYP2E1 gene expression (Tsutsumi et al., 1993) and that ZCyd is a cyti-
dine analog which is able to reduce DNAmethylation towards its inhib-
itory effect on the methyltransferase enzyme DNMTs, so as to be called
“DNMT inhibitor of reference” (Ceccaldi et al., 2013).
Ourworking hypothesis predicted that using these two drugs in par-
allel could givemore information, direct and indirect, about the CYP2E1
methylation site function. By treatment with a speciﬁc gene-inducer
it would be possible to verify if the methylation sites must necessarily
decrease to permit the enzyme expression. In contrast, treating the
cells with a drug able to reduce DNA methylation in a non-speciﬁc
way, it was possible to know whether, forcing the demethylation of
sites, the gene was also expressed in the absence of its own speciﬁc
inducer.
Table 2
Genomic methylation changes observed in DNA ﬁngerprintings of untreated and ZCyd-
treated cell lines.
Cell Lines ZCyd
(μM)
Fragment pattern variation Total of variations
Appearing or
disappearing
Attenuation or
intensiﬁcation
Chang liver 0 0 1 1
1 0 1 1
2.5 1 0 1
5 1 0 1
10 5 0 5
Σ 7 2 9
HAH7 0 1 3 4
1 0 4 4
2.5 1 5 6
5 1 1 2
10 0 6 6
Σ 2 19 21
HepG2 0 3 3 6
1 2 3 5
2.5 2 7 9
5 2 1 3
10 4 1 5
Σ 13 15 28.⁎
HUH7 0 0 2 2
1 1 3 4
2.5 1 3 4
5 2 1 3
10 6 1 7
Σ 10 10 20
⁎ 0.01 b p b 0.05, according to Student's t test.
Fig. 4.Histograms indicating, in arbitrary units, the results of densitometer scanning ofWestern blotting signals of CYP2E1 enzyme expression obtained normalizing every (un)treated cell
line expression against respective β-tubulin value and relating it with untreated control set as 1. Data were expressed as mean ± SD from three independent experiments.
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DNA methylation data of the gene in untreated cells showed that
both sites in all cell lines, with the unique exception (2M site in
HepG2 cells), are hypermethylated suggesting that this condition corre-
sponds to a basic DNA methylation level of the gene in unstimulated
cells. The DNA methylation analysis of the two sites (1M and 2M,
Fig. 2) in ethanol- or ZCyd-treated cells showed no consistent results
in the four cell lines. In particular, either increasing the ethanol
dose or exposing to ZCyd escalating treatment, the two methylation
sites showed a heterogeneous behavior. Looking at these results, it is
difﬁcult to glimpse for these two inductors a direct relation between
Fig. 5. Simultaneous graphic representation of ethanol- (left) or ZCyd- (right) inducted enzyme expression and DNA methylation status of the two sites 1M and 2M of the CYP2E1 5′-
ﬂanking region in the four cell lines. The enzyme expression is indicated in arbitrary units as the results of densitometer scanning ofWestern blotting signals normalized against respective
β-tubulin value and relatedwith untreated control set as 1; datawere expressed asmean ± SD from three independent experiments. TheDNAmethylation data were obtained byMSRE-
PCR and the relative error bars represent the variable number of methylated cytosines obtained upon MspI enzyme methylation sensitivity.
Fig. 6. Simultaneous graphic representation of untreated (A) and ethanol- or ZCyd- (B) induced enzyme expression and polymorphisms genotypes (reported below) in the hepatic cell
lines. The enzyme expression is indicated in arbitrary units as the results of densitometer scanning of Western blotting signals normalized against respective β-tubulin value and related
with untreated control cell line (Chang liver cells) set as 1; data were expressed as mean ± SD from three independent experiments.
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doses–response in terms of treatment and demethylation of the 1M
and 2M sites.
We could say that the two inducers, theﬁrst CYP2E1-speciﬁc and the
second speciﬁc for all the DNA methylation-regulated genes, cause a
general reduction of methylation at all two sites of cancer cell lines
(HepG2, Huh7 and HA22T) but we have also to report that neither
ethanol nor ZCyd is able to reduce, in any dose and time conditions,
the CYP2E1 DNA methylation in the non-neoplastic Chang Liver cells.
It is well known that the genomes of normal cells are globally more
highly methylated than those of cancer cells (Gama-Sosa et al., 1983):
within this scenario, our data conﬁrm that, at least for the CYP2E1 pro-
moter, the normal cells appear insensitive to the inducer-agent action.
Finally, seeing the data in cancer cells, it is possible to observe that
the 2M site is overall more sensitive to the reduction of methylation
rather than the site 1M; remembering that this site, between the two,
is the closest to the start site, it would be possible to assign to the 2M
site a more dynamic ability to modulate their methylation status in re-
lation to external stimuli.
DNA methylation was investigated in all the four cell lines treated
or not with ZCyd, at genome level too. Results (Fig. 3 and Table 2)
of MeSAP-PCR were in agreement with those obtained by MSRE-PCR
for CYP2E1 gene, showing an overlap between genomic- and gene-
level. A generalized decrease in DNA methylation was observed in
ZCyd-treated cells compared to untreated and this behavior happened
more in HCC cells than in Chang liver, conﬁrming the well-known
genomewide demethylating effect of ZCyd. In particular, the genome
of HepG2 cells was found to be the most sensible to hypomethylation
ZCyd-induced, showing signiﬁcant differences (p b 0.05) in DNAmeth-
ylation changes with respect to the untreated. Conversely, Chang liver
cells exhibited their genome hypermethylated both in basal conditions
and under ZCyd-treatment, as can be seen by the low number of meth-
ylation changes.
4.4. Multiple correlation between ethanol- or ZCyd-inducted enzyme
expression and CYP2E1 5′ ﬂanking region DNA methylation
Since the histograms showed in Fig. 4 failed to give us a clear relation
between induction of ethanol or ZCyd and enzyme expression, we
performed a multiple correlation between ethanol- or ZCyd-inducted
enzyme expression and CYP2E1 5′ ﬂanking region DNA methylation,
carrying out an integrated approach of these data. The results (Fig. 5)
are not easy to interpret: in fact, it is evident that both ethanol and
ZCyd inﬂuenced the CYP2E1 enzyme expression but it is equally evident
that this inﬂuence did not appear to follow the logical path of the
increase of enzyme expression consistent to a reduction of methylation,
ethanol- or ZCyd-inducted. However, the results suggest a complex
control-mechanism with several actors (not yet all known), each of
which, differently inﬂuenced by the reduction of methylation, induces
the enzyme expression in its own way. Therefore, the regulation of
the expression of the CYP2E1 enzyme is more complex than initially
proposed (Köhler and Roos, 2008). Finally, these data conﬁrm that,
within the 5′ ﬂanking region, the two methylation sites behave differ-
ently suggesting that they play different roles and functions in control-
ling the enzyme expression.
4.5. Multiple correlation between ethanol or ZCyd-inducted CYP2E1
enzyme expression and CYP2E1 polymorphic genotypes
A secondmultiple correlation, according to thementioned integrated
approach, was performed between ethanol- or ZCyd-inducted CYP2E1
enzyme expression and CYP2E1 polymorphic genotypes. We integrated
the data of CYP2E1 enzyme expression in untreated cells with possessed
polymorphic genotypes with the aim to assess the inﬂuence of these
genetics elements in enzyme expression. In fact, it is important to consid-
er not only the methylation status of the cytosines of promoter, in an
exclusive epigenetic approach, but also to associate genetic data about
particular polymorphic genotypes, which is known to confer different
gene expression, equally to gene methylation (Witkin et al., 2000).
Several studies were conducted on this gene with regard to the
presence of Restriction Fragment Length Polymorphisms (RFLP) for
the enzymes RsaI and PstI in the CYP2E1 5′ ﬂanking region (Watanabe
et al., 1990), as well as the effects of these polymorphisms in the tran-
scriptional activity of the gene (Hayashi et al., 1991).
An interesting ﬁnding reported in this study (Table 1 and Fig. 6) is
that all the used cell lines had a similar non-canonical Rsa/Pst genotype
association, and in particular, that the HepG2 cells possessed an extra
RsaI site with respect to the other cell lines; the Rsa I polymorphism is
known to be particularly important for the transcriptional activity of
Fig. 7. Electrophoretic Mobility Shift Assay (EMSA) of cloned VNTR CYP2E1 A2 and A3 alleles put in presence of the Chang liver total protein extract. (A) Chemoluminescent detection.
(B) Ethidium bromide-stained gel electrophoresis, catched before chemoluminescent detection.
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the CYP2E1 gene, since it is a binding site of HNF-1 factor (Fig. 1) to the
promoter (Watanabe et al., 1995). A single nucleotide change in this
position alters the binding proﬁle of HNF-1 resulting in a marked
change in the transcriptional activation of gene.
Since these cell lines showed a similar Rsa/Pst polymorphic geno-
type, we were able to interpret the enzyme expression as resulting
from the contribution of VNTR genotype only. Little is known about
the relation between VNTR CYP2E1 polymorphisms and their inﬂuence
in enzyme expression. Uchimoto et al. (2007) reported that these poly-
morphisms are involved in the negative regulation of transcription of
the CYP2E1 gene. The data reported here (Fig. 6A) show the greater in-
hibitory effect of A4/A4 genotype (containing more repetitive units),
compared with the A2/A2 (containing less repetitive units); further-
more, our data ﬁrstly provide a quantitative estimation of the negative
inﬂuence of the A4/A4 genotype with respect to A2/A2 in the enzyme
expression. In fact, untreated HepG2 and HUH7 cells, carrying both
A4/A4 genotype, showed an enzyme expression of less than or about
20% and 30% respectively, compared to untreated Chang Liver cells,
and this small difference could be derived by the Rsa/Pst genotype,
having HepG2 as an extra RsaI site. Similarly, we are able to describe
for the ﬁrst time the positive inﬂuence of the A2/A3 genotype in
CYP2E1 expression: untreated HA22T cells, carrying A2/A3 genotype,
showed about 25% fold increased of enzyme expression in comparison
to the reference cells. These results, obtained from a panel of four cell
lines, homogenous for the tissue origin, phenotypically different, being
tumor and non-neoplastic cell line, were sufﬁcient to let us to formulate
a reasonable explanation, and to suppose some hypothetical roles and
actors. We think that the expression of the enzyme could be mainly
inﬂuenced by the polymorphic genotypes, more by VNTR rather than
Rsa/Pst. These differences, together with hypothetical additional
DNA methylation-sensitive regulatory elements, as well as post-
transcriptional and post-translational mechanisms, could explain the
inconsistent epigenetic behaviors previously showed.
Soichot et al. (2011) reported that VNTR sequences in the promoter
of the IDO1 gene are binding site for trans-acting factors and that the oc-
curred bindingmitigates the VNTR inhibitory effect on gene expression.
In this scenario, we considered reasonable to investigate whether the
CYP2E1 VNTR polymorphisms may also be a binding site for trans-
acting factors, expressed by other genes, and whether this association
may modulate the inhibitory effect of VNTR repeats onto CYP2E1 gene
expression. Whereas the increase of the enzyme expression cannot be
ascribed to the demethylation of CYP2E1 sites or to the Rsa/Pst poly-
morphisms, we formulate the work-hypothesis that this increase was
caused by the demethylation, ZCyd-induced, of promoters with conse-
quent expression of other genes that encode for various CYP2E1 effector
proteins, either inhibiting or activating the CYP2E1 gene expression.
These effectors, taking a selective contact with each VNTR region,
could act differently depending on their own nature and of VNTR allele
length they bind to. In particular, the largest VNTR A4 allele didn't bind
any protein(s), then, with respect to the untreated cells, a decreased
expression of CYP2E1 gene occurred, especially in the presence of an
A4/A4 homozygous genotype and two Rsa I sites (as it was observed
in HepG2 cells, Fig. 6B). An inhibitory effect was conversely evident in
the presence of shorter A3 allele, as it was seen in Ha22T cells. Surpris-
ingly HUH7 cells, having the same A4/A4 genotype of HepG2, showed a
ZCyd-induced increase of enzyme expression. It is worth mentioning
that these cells had with respect to HepG2, a different haplotype Rsa/
Pst for the presence of only one Rsa I sites.
In a previous paper we hypothesized that the A4/A4 genotype may
be a high-risk genotype during the early stages of cancer (Catanzaro
et al., 2012a) and in particular for pancreatic adenocarcinoma. In light
of the data showed here, since it is well known that the genome of a
tumor cell is globally demethylated (as that of a ZCyd-treated cell) we
conﬁrmed our previous hypothesis and launch the idea that having
the A4/A4 genotype for a tumor cell is a selective advantage, especially
when the same cell is gradually demethylating its own genome.
All the data referred here regarding ethanol treatment (Fig. 6B)
seem to be confusing and often not in agreement with the others. In
a recent paper, Balusikova and Kovar (2013) demonstrated, just in
HepG2 cells, that only the long term exposure of ethanol can give an
effect on CYP2E1 expression: thus, it is possible that the lack of clarity
in the results reported here is in relationship to the short time of ethanol
exposurewe used. On the contrary, we think that our apparently incon-
sistent results, obtained using ethanol, are a conﬁrmation of hypothesis
regarding the ZCyd induction of other gene coding for CYP2E1 effector
proteins. In fact, as it is well known, ethanol is a speciﬁc inducer of
CYP2E1 gene and, unlike ZCyd, cannot act on other genes.
4.6. VNTR allele–protein interactions studies
In order to conﬁrm or discard the hypothesis that VNTR polymor-
phisms are binding sites for trans-acting factors that can modulate the
expression of the CYP2E1 enzyme, the Electrophoretic Mobility Shift
Assays (EMSA) was carried out for the alleles A2 and A3, which were
seen to be associated with an increased expression of the CYP2E1 en-
zyme in the untreated cells Ha22T carrying the two alleles. Thus, ampli-
ﬁed VNTR regionswere put in the presence of nuclear protein extract to
differentiate the electrophoretic mobility of the DNA–protein complex
compared to boundless DNA. A series of special features, either in the
design and in the execution phase, preceded theplanning and execution
of the EMSA test. Firstly, we cloned the ampliﬁed fragments containing
the VNTR alleles in plasmid vector and performed EMSA with PCR
products obtained from ampliﬁcation of speciﬁc VNTR clones, veriﬁed
both with restriction analysis and sequencing: this in order to avoid
unspeciﬁc results, strongly probable if it was chosen to use ampliﬁed re-
petitive regions (such as VNTR) obtained directly from genomic DNA.
Finally, for each allele, we planned to repeat the test in the presence of
speciﬁc, unspeciﬁc competitors and, more importantly, using a large
amount of unlabeled VNTR A4 allele as negative control, since it must
not bind any speciﬁc protein, according to our hypothesis. All these pre-
cautions made the assay able to discriminate speciﬁc DNA–protein
binding complex.
By looking at the results obtained (Fig. 7A), it is evident that the
CYP2E1 VNTR alleles A2 and A3 possess binding sites for proteins and
also that they are speciﬁc for these DNA fragments. Furthermore, as
it is clear by looking at the ethidium bromide-stained gel (Fig. 7B), the
differential mobility shift displayed between the two alleles showed
that the related factors are different for the two tested alleles and this
could justify their dissimilar inﬂuence in enzyme expression (Fig. 6A).
This study, demonstrating for the ﬁrst time that the VNTR alleles
A2 and A3 of the CYP2E1 gene bind speciﬁc proteins, contributes to
deﬁne a hypothetical model of regulation of the expression of this
enzyme. It will be necessary to characterize the protein binding the
VNTR alleles to clarify the complex regulation of CYP2E1 enzyme ex-
pression, either by genetic or epigenetic elements, to give useful topics
in pharmacogenomics, for typing people regarding its metabolizing
capability and therapy response, in oncology, for the diagnosis and
therapy of hepatocellular carcinoma, or in the social, for the relation
between CYP2E1 gene and alcoholism.
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